FDA drug chief hints at potential departure amid growing agency turmoil
Dr. Cavazzoni, who has led the FDA’s Center for Drug Evaluation and Research since 2020, has been a prominent figure during critical moments, including the expedited approval of COVID-19 vaccines. However, recent controversies surrounding the agency’s decision-making processes have contributed to a climate of uncertainty, prompting speculation about her future. Reports suggest that her departure … Read more